- Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
- About Regeneron | Our Company
Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases
- Regeneron Careers - The Future of Medicine is unscripted.
Asia EMEA North America Working at Regeneron We are a team of original thinkers who work together to create life-transforming medicines for people with serious diseases Whether it's in the laboratory or at lunch, our company is built on breakthrough ideas, diverse personal strengths and a culture of connection
- Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
- Regeneron Announces New Investment in Manufacturing of its Industry . . .
New manufacturing and supply agreement with FUJIFILM Diosynth Biotechnologies in North Carolina will enable additional production of Regeneron’s biologic medicines and support high-paying jobs in the region
- PUSH THE BOUNDS OF SCIENCE - Regeneron
Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing life-transforming medicines for people with serious diseases
- Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, News, Quote . . .
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation
- Regeneron tries to revamp relationship between pharma, patient . . . - STAT
Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a point of concern for investors
|